Integra Lifesciences (IART)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2008 | 12-2007 | 12-2006 | 12-2005 | 12-2004 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 183,546 | 57,339 | 22,697 | 46,889 | 69,855 |
| Marketable Securities | N/A | N/A | N/A | 80,327 | 30,955 |
| Receivables | 112,417 | 103,539 | 85,018 | 49,007 | 46,765 |
| Inventories | 146,103 | 144,535 | 94,387 | 67,476 | 55,947 |
| Income taxes - deferred | 24,135 | 22,254 | 10,010 | 10,842 | 3,966 |
| TOTAL | $497,392 | $339,931 | $221,761 | $265,952 | $216,238 |
| Non-Current Assets | |||||
| PPE Net | 76,003 | 61,730 | 42,559 | 27,451 | 25,461 |
| Investments And Advances | 0 | 0 | 0 | 16,168 | 95,172 |
| Intangibles | 438,092 | 403,204 | 342,130 | 132,933 | 99,054 |
| Other Non-Current Assets | 14,527 | 13,147 | 7,168 | 5,928 | 20,788 |
| TOTAL | $528,622 | $478,081 | $391,857 | $182,480 | $240,475 |
| Total Assets | $1,026,014 | $818,012 | $613,618 | $448,432 | $456,713 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | N/A | 119,962 | 119,542 | N/A | N/A |
| Accounts payable and accrued liabilities | 22,964 | 23,232 | 20,329 | 8,978 | 10,160 |
| Accrued Expenses | 48,734 | 45,576 | 29,827 | 21,506 | 13,052 |
| TOTAL | $174,751 | $191,671 | $274,017 | $31,287 | $24,234 |
| Non-Current Liabilities | |||||
| Long Term Debt | 160,000 | N/A | N/A | N/A | 118,900 |
| Deferred Revenues | 3,053 | 2,901 | 4,319 | 88 | N/A |
| Other Non-Current Liabilities | 318,954 | 349,860 | 12,083 | 124,807 | 5,756 |
| TOTAL | $478,954 | $365,912 | $43,439 | $127,327 | $124,656 |
| Total Liabilities | $653,705 | $557,583 | $317,456 | $158,614 | $148,890 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,286 | 54,614 | 54,655 | 56,870 | 58,623 |
| Common Shares | 344 | 323 | 315 | 298 | 292 |
| Retained earnings | 116,206 | 98,175 | 66,336 | 36,929 | -265 |
| Other shareholders' equity | 4,975 | 18,665 | 8,234 | -4,588 | 6,194 |
| TOTAL | $372,309 | $260,429 | $296,162 | $289,818 | $307,823 |
| Total Liabilities And Equity | $1,026,014 | $818,012 | $613,618 | $448,432 | $456,713 |